Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
暂无分享,去创建一个
Haruo Watanabe | R. Colwell | A. Huq | R. Sack | S. Rashed | Munirul Alam | A. Sadique | Fatema-tuz Johura | A. Cravioto | S. B. Mannan | M. T. Islam | S. Mannan | M. T. Islam
[1] Y. Takeda,et al. Development and Evaluation of a PCR Assay for Tracking the Emergence and Dissemination of Haitian Variant ctxB in Vibrio cholerae O1 Strains Isolated from Kolkata, India , 2012, Journal of Clinical Microbiology.
[2] A. Vicente,et al. Variants of Vibrio cholerae O1 El Tor from Zambia showed new genotypes of ctxB , 2011, Epidemiology and Infection.
[3] N. A. Bhuiyan,et al. Variants of Vibrio cholerae O1 El Tor from Zambia showed new genotypes of ctxB: a reply to Marin & Vicente , 2011, Epidemiology and Infection.
[4] Julian Parkhill,et al. Evidence for several waves of global transmission in the seventh cholera pandemic , 2011, Nature.
[5] M. Jain,et al. Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India. , 2011, Acta tropica.
[6] James H. Bullard,et al. The origin of the Haitian cholera outbreak strain. , 2011, The New England journal of medicine.
[7] M. Quilici,et al. Vibrio cholerae O1 Variant with Reduced Susceptibility to Ciprofloxacin, Western Africa , 2010, Emerging infectious diseases.
[8] N. Taneja,et al. Emergence of tetracycline resistance in Vibrio cholerae O1 biotype El Tor serotype Ogawa from north India. , 2010, Indian journal of pathology & microbiology.
[9] A. Goel,et al. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[10] Armando Navarro,et al. Cholera between 1991 and 1997 in Mexico Was Associated with Infection by Classical, El Tor, and El Tor Variants of Vibrio cholerae , 2010, Journal of Clinical Microbiology.
[11] Sabu Thomas,et al. Characterization of an SXT variant Vibrio cholerae O1 Ogawa isolated from a patient in Trivandrum, India. , 2010, FEMS microbiology letters.
[12] Bradd J. Haley,et al. Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae , 2009, Proceedings of the National Academy of Sciences.
[13] A. Nizam,et al. El Tor cholera with severe disease: a new threat to Asia and beyond , 2009, Epidemiology and Infection.
[14] G. Nair,et al. A large cholera outbreak due to a new cholera toxin variant of the Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India. , 2009, Journal of medical microbiology.
[15] A. Safa,et al. Vibrio cholerae O1 Hybrid El Tor Strains, Asia and Africa , 2008, Emerging infectious diseases.
[16] R. Colwell,et al. Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission , 2007, Proceedings of the National Academy of Sciences.
[17] M. A. Malek,et al. Emergence of Multidrug-resistant Strain of Vibrio cholerae O1 in Bangladesh and Reversal of Their Susceptibility to Tetracycline after Two Years , 2007, Journal of health, population, and nutrition.
[18] Y. Takeda,et al. Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh , 2006, Journal of Clinical Microbiology.
[19] M. Bennish,et al. Single-dose azithromycin for the treatment of cholera in adults. , 2006, The New England journal of medicine.
[20] Anwar Huq,et al. Seasonal Cholera Caused by Vibrio cholerae Serogroups O1 and O139 in the Coastal Aquatic Environment of Bangladesh , 2006, Applied and Environmental Microbiology.
[21] J. Terajima,et al. Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. , 2006, Foodborne pathogens and disease.
[22] Amita,et al. Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India , 2002, Antimicrobial Agents and Chemotherapy.
[23] D. Sack,et al. New Variants of Vibrio cholerae O1 Biotype El Tor with Attributes of the Classical Biotype from Hospitalized Patients with Acute Diarrhea in Bangladesh , 2002, Journal of Clinical Microbiology.
[24] John F. Heidelberg,et al. Comparative genomic analysis of Vibrio cholerae: Genes that correlate with cholera endemic and pandemic disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. Yuen,et al. Detection of RTX Toxin Gene in Vibrio cholerae by PCR , 2001, Journal of Clinical Microbiology.
[26] Amit Ghosh,et al. Diverse CTXΦs and evolution of new pathogenic Vibrio cholerae , 1998, The Lancet.
[27] S. Yamasaki,et al. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. , 1998, FEMS immunology and medical microbiology.
[28] M. Waldor,et al. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139 , 1996, Journal of bacteriology.
[29] Amit Pal,et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.
[30] T. Popović,et al. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains , 1993, Journal of clinical microbiology.
[31] C. Pazzani,et al. Clonal spread of multiply resistant strains of Vibrio cholerae O1 in Somalia. , 1986, The Journal of infectious diseases.
[32] R. Glass,et al. Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh. , 1983, The Journal of infectious diseases.
[33] R. Glass,et al. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. , 1980, The Journal of infectious diseases.
[34] F. Mhalu,et al. RAPID EMERGENCE OF EL TOR VIBRIO CHOLERA RESISTANT TO ANTIMICROBIAL AGENTS DURING FIRST SIX MONTHS OF FOURTH CHOLERA EPIDEMIC IN TANZANIA , 1979, The Lancet.
[35] A. Bauer,et al. Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.
[36] A. Benenson,et al. TETRACYCLINE IN THE TREATMENT OF CHOLERA. , 1964, Lancet.
[37] Samir N. Patel,et al. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .
[38] S. Faruque,et al. Aetiological, clinical and epidemiological characteristics of a seasonal peak of diarrhoea in Dhaka, Bangladesh. , 1998, Scandinavian journal of infectious diseases.
[39] Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. , 1993, Lancet.
[40] M. Jesudason,et al. Transferable trimethoprim resistance of Vibrio cholerae O1 encountered in southern India. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[41] M. Islam,et al. Antibiotic therapy of cholera. , 1967, Bulletin of the World Health Organization.